Cargando…

Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury

Cerebral ischemic reperfusion injury (CI/RI) is a critical factor that leads to a poor prognosis in patients with ischemic stroke. It is an extremely complicated pathological process that is clinically characterized by high rates of disability and mortality. Current available treatments for CI/RI, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ping, Wan, Haitong, Shao, Chongyu, Li, Chang, Zhang, Ling, He, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801784/
https://www.ncbi.nlm.nih.gov/pubmed/35111041
http://dx.doi.org/10.3389/fphar.2021.688596
_version_ 1784642539803901952
author Huang, Ping
Wan, Haitong
Shao, Chongyu
Li, Chang
Zhang, Ling
He, Yu
author_facet Huang, Ping
Wan, Haitong
Shao, Chongyu
Li, Chang
Zhang, Ling
He, Yu
author_sort Huang, Ping
collection PubMed
description Cerebral ischemic reperfusion injury (CI/RI) is a critical factor that leads to a poor prognosis in patients with ischemic stroke. It is an extremely complicated pathological process that is clinically characterized by high rates of disability and mortality. Current available treatments for CI/RI, including mechanical and drug therapies, are often accompanied by significant side effects. Therefore, it is necessary to discovery new strategies for treating CI/RI. Many studies confirm that Chinese herbal medicine (CHM) was used as a potential drug for treatment of CI/RI with the advantages of abundant resources, good efficacy, and few side effects. In this paper, we investigate the latest drug discoveries and advancements on CI/RI, make an overview of relevant CHM, and systematically summarize the pathophysiology of CI/RI. In addition, the protective effect and mechanism of related CHM, which includes extraction of single CHM and CHM formulation and preparation, are discussed. Moreover, an outline of the limitations of CHM and the challenges we faced are also presented. This review will be helpful for researchers further propelling the advancement of drugs and supplying more knowledge to support the application of previous discoveries in clinical drug applications against CI/RI.
format Online
Article
Text
id pubmed-8801784
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88017842022-02-01 Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury Huang, Ping Wan, Haitong Shao, Chongyu Li, Chang Zhang, Ling He, Yu Front Pharmacol Pharmacology Cerebral ischemic reperfusion injury (CI/RI) is a critical factor that leads to a poor prognosis in patients with ischemic stroke. It is an extremely complicated pathological process that is clinically characterized by high rates of disability and mortality. Current available treatments for CI/RI, including mechanical and drug therapies, are often accompanied by significant side effects. Therefore, it is necessary to discovery new strategies for treating CI/RI. Many studies confirm that Chinese herbal medicine (CHM) was used as a potential drug for treatment of CI/RI with the advantages of abundant resources, good efficacy, and few side effects. In this paper, we investigate the latest drug discoveries and advancements on CI/RI, make an overview of relevant CHM, and systematically summarize the pathophysiology of CI/RI. In addition, the protective effect and mechanism of related CHM, which includes extraction of single CHM and CHM formulation and preparation, are discussed. Moreover, an outline of the limitations of CHM and the challenges we faced are also presented. This review will be helpful for researchers further propelling the advancement of drugs and supplying more knowledge to support the application of previous discoveries in clinical drug applications against CI/RI. Frontiers Media S.A. 2022-01-17 /pmc/articles/PMC8801784/ /pubmed/35111041 http://dx.doi.org/10.3389/fphar.2021.688596 Text en Copyright © 2022 Huang, Wan, Shao, Li, Zhang and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Huang, Ping
Wan, Haitong
Shao, Chongyu
Li, Chang
Zhang, Ling
He, Yu
Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
title Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
title_full Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
title_fullStr Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
title_full_unstemmed Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
title_short Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury
title_sort recent advances in chinese herbal medicine for cerebral ischemic reperfusion injury
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801784/
https://www.ncbi.nlm.nih.gov/pubmed/35111041
http://dx.doi.org/10.3389/fphar.2021.688596
work_keys_str_mv AT huangping recentadvancesinchineseherbalmedicineforcerebralischemicreperfusioninjury
AT wanhaitong recentadvancesinchineseherbalmedicineforcerebralischemicreperfusioninjury
AT shaochongyu recentadvancesinchineseherbalmedicineforcerebralischemicreperfusioninjury
AT lichang recentadvancesinchineseherbalmedicineforcerebralischemicreperfusioninjury
AT zhangling recentadvancesinchineseherbalmedicineforcerebralischemicreperfusioninjury
AT heyu recentadvancesinchineseherbalmedicineforcerebralischemicreperfusioninjury